MXPA02008072A - Composicion farmaceutica. - Google Patents
Composicion farmaceutica.Info
- Publication number
- MXPA02008072A MXPA02008072A MXPA02008072A MXPA02008072A MXPA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A
- Authority
- MX
- Mexico
- Prior art keywords
- membrane
- nail
- solvent
- solution
- permeation enhancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describe una composicion que comprende un compuesto farmaceutico, un aumentador de la permeacion de membrana, y un agente polimerico que forma una pelicula, que incluye, por ejemplo, una laca liquida de unas con base en hidrocarburo que comprende una solucion de un agente anti-fungal en una cantidad farmaceuticamente efectiva, un aumentador de la permeacion compatible con la membrana en una cantidad efectiva para aumentar la penetracion a traves de la membrana o de la una del agente anti-fungal, un agente polimerico que forma una pelicula en una cantidad efectiva para formar una pelicula polimerica adherente en la membrana o la una, y un solvente para formar la solucion; y un metodo para formar en la membrana o la una del cuerpo una pelicula adherente que contiene el compuesto farmaceutico y el aumentador de la permeacion de una solucion de los componentes en los cuales se usa una mezcla de solventes, que incluye un solvente que es altamente volatil y un solvente con una volatilidad menor.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18292400P | 2000-02-16 | 2000-02-16 | |
PCT/US2001/005302 WO2001060325A1 (en) | 2000-02-16 | 2001-02-16 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02008072A true MXPA02008072A (es) | 2004-04-05 |
Family
ID=22670647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02008072A MXPA02008072A (es) | 2000-02-16 | 2001-02-16 | Composicion farmaceutica. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1257248B1 (es) |
JP (1) | JP2005503318A (es) |
KR (2) | KR20080049148A (es) |
CN (1) | CN1422142A (es) |
AT (1) | ATE526917T1 (es) |
AU (2) | AU2001243189B2 (es) |
BR (1) | BR0108438A (es) |
CA (1) | CA2400178A1 (es) |
HU (1) | HUP0204555A3 (es) |
MA (1) | MA26883A1 (es) |
MX (1) | MXPA02008072A (es) |
NO (1) | NO20023866L (es) |
NZ (1) | NZ520749A (es) |
PL (1) | PL357111A1 (es) |
TW (1) | TWI232756B (es) |
WO (1) | WO2001060325A1 (es) |
ZA (1) | ZA200206553B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6585963B1 (en) * | 2001-02-15 | 2003-07-01 | Watson Pharmaceuticals, Inc. | Nail compositions and methods of administering same |
GB0203276D0 (en) * | 2002-02-12 | 2002-03-27 | Novartis Ag | Organic compounds |
DK1545619T3 (da) | 2002-09-05 | 2008-05-26 | Galderma Sa | Oplösning til ungual påföring |
KR101093990B1 (ko) * | 2003-03-21 | 2011-12-16 | 넥스메드 홀딩스 인코포레이티드 | 항진균성 네일 코트 및 사용 방법 |
US8741333B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
US8741332B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for dermally treating neuropathic pain |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
JP5010125B2 (ja) * | 2005-09-02 | 2012-08-29 | 有限会社日本健康科学研究センター | 水虫治療用フィルム製剤 |
EP1947938A4 (en) * | 2005-11-02 | 2009-07-01 | Cpex Pharmaceuticals Inc | MACROCYCLIC FORMULATIONS FOR TRANSMEMBRANE DRUG DELIVERY |
AU2006326388B2 (en) * | 2005-12-14 | 2013-01-24 | Nuvo Research Inc. | Compositions and methods for treating dermatological conditions |
JP5290582B2 (ja) * | 2005-12-28 | 2013-09-18 | 帝國製薬株式会社 | 爪用医薬組成物 |
US20100028447A1 (en) | 2007-01-22 | 2010-02-04 | Targacept, Inc. | Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs |
JP5654497B2 (ja) * | 2009-02-13 | 2015-01-14 | トピカ ファーマシューティカルズ,インコーポレイテッド | 抗真菌製剤 |
EP2408299B1 (en) * | 2009-03-20 | 2013-10-23 | Stiefel Laboratories, Inc. | Fatty acid monoglyceride compositions |
GB201021386D0 (en) * | 2010-12-16 | 2011-01-26 | Burke Michael H | A process for the manufacture of an antifungal nail lacquer |
LT2782584T (lt) | 2011-11-23 | 2021-09-10 | Therapeuticsmd, Inc. | Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
KR101580077B1 (ko) | 2015-03-28 | 2015-12-24 | 한국콜마주식회사 | 시크로피록스 함유 네일락카 조성물 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4299826A (en) * | 1979-10-12 | 1981-11-10 | The Procter & Gamble Company | Anti-acne composition |
US5023252A (en) * | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
US5731303A (en) * | 1985-12-04 | 1998-03-24 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery compositions |
DE3720147A1 (de) * | 1987-06-16 | 1988-12-29 | Hoechst Ag | Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung |
EP0503312B1 (fr) * | 1991-03-13 | 1997-01-08 | Firmenich Sa | Procédé de préparation de la 15-pentadécanolide ou de mélanges riches en cette macrolide |
EP0805673A1 (en) * | 1994-10-20 | 1997-11-12 | The Procter & Gamble Company | Personal treatment compositions and/or cosmetic compositions containing enduring perfume |
US5693828A (en) * | 1996-05-09 | 1997-12-02 | International Flavors & Fragrances Inc. | Process for preparing lactones and intermediates therefor |
PT983037E (pt) * | 1998-02-09 | 2003-09-30 | Macrochem Corp | Verniz para unhas antifungico |
US6231875B1 (en) * | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
US6495124B1 (en) * | 2000-02-14 | 2002-12-17 | Macrochem Corporation | Antifungal nail lacquer and method using same |
-
2001
- 2001-02-16 CN CN01807713A patent/CN1422142A/zh active Pending
- 2001-02-16 KR KR1020087011722A patent/KR20080049148A/ko not_active Application Discontinuation
- 2001-02-16 MX MXPA02008072A patent/MXPA02008072A/es not_active Application Discontinuation
- 2001-02-16 PL PL01357111A patent/PL357111A1/xx not_active Application Discontinuation
- 2001-02-16 EP EP01916128A patent/EP1257248B1/en not_active Expired - Lifetime
- 2001-02-16 TW TW090103582A patent/TWI232756B/zh not_active IP Right Cessation
- 2001-02-16 AT AT01916128T patent/ATE526917T1/de not_active IP Right Cessation
- 2001-02-16 HU HU0204555A patent/HUP0204555A3/hu unknown
- 2001-02-16 BR BR0108438-0A patent/BR0108438A/pt not_active IP Right Cessation
- 2001-02-16 WO PCT/US2001/005302 patent/WO2001060325A1/en active IP Right Grant
- 2001-02-16 KR KR1020027010571A patent/KR20030016227A/ko active Search and Examination
- 2001-02-16 AU AU2001243189A patent/AU2001243189B2/en not_active Ceased
- 2001-02-16 CA CA002400178A patent/CA2400178A1/en not_active Abandoned
- 2001-02-16 NZ NZ520749A patent/NZ520749A/en unknown
- 2001-02-16 JP JP2001559423A patent/JP2005503318A/ja active Pending
- 2001-02-16 AU AU4318901A patent/AU4318901A/xx active Pending
-
2002
- 2002-08-15 ZA ZA200206553A patent/ZA200206553B/en unknown
- 2002-08-15 NO NO20023866A patent/NO20023866L/no not_active Application Discontinuation
- 2002-09-11 MA MA26811A patent/MA26883A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
KR20030016227A (ko) | 2003-02-26 |
CN1422142A (zh) | 2003-06-04 |
ZA200206553B (en) | 2003-11-17 |
PL357111A1 (en) | 2004-07-12 |
NZ520749A (en) | 2004-06-25 |
CA2400178A1 (en) | 2001-08-23 |
KR20080049148A (ko) | 2008-06-03 |
JP2005503318A (ja) | 2005-02-03 |
NO20023866L (no) | 2002-10-01 |
NO20023866D0 (no) | 2002-08-15 |
EP1257248B1 (en) | 2011-10-05 |
ATE526917T1 (de) | 2011-10-15 |
EP1257248A1 (en) | 2002-11-20 |
HUP0204555A2 (en) | 2003-05-28 |
MA26883A1 (fr) | 2004-12-20 |
AU4318901A (en) | 2001-08-27 |
HUP0204555A3 (en) | 2004-06-28 |
WO2001060325A1 (en) | 2001-08-23 |
EP1257248A4 (en) | 2007-10-03 |
AU2001243189B2 (en) | 2005-06-09 |
TWI232756B (en) | 2005-05-21 |
BR0108438A (pt) | 2003-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02008072A (es) | Composicion farmaceutica. | |
UA27143C2 (uk) | Рідка фармацевтичhа композиція в формі аерозолю | |
NZ330136A (en) | Stable liquid paracetamol compositions comprising polyhydric or water soluble alcanol and buffering agent, and further containing a free radical antagonist or scavenger | |
BG103221A (en) | Pharmaceutical composition in aerosol form | |
WO1995001167A3 (en) | Incorporating poly-n-vinyl amide in a transdermal system | |
MY101536A (en) | Anti-inflammatory and analgesic tape for external use | |
JP2005503318A5 (es) | ||
WO2005099676A3 (en) | Transdermal delivery system for use with basic permeation enhancers | |
TNSN04080A1 (en) | Method and composition for improving fuel combustion | |
GEP20033129B (en) | Pressurised Metered Dose Inhalers and Aerosol Formulation | |
NZ504653A (en) | Cosmetic compositions with dibenzylidene sorbitol and functionalized silicones | |
MY130857A (en) | Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents | |
BR9505201A (pt) | Agente de extração de tinta alcalino contendo álcool benzilico como em sistema solvente composição para extração de tinta e processos de preparação de um removedor de alcalino de revestimento ou emuls o água-em-óleo de agente de extração de tinta e de extrção de tinta de poliuterano sobre uma camada de primeira mão de epóxi sobre metal | |
NO954957L (no) | Synergistisk stabiliserte flytende enzymatiske blandinger | |
WO2001055092A3 (de) | 5-aminolävulinsäure-formulierung in nichtwässrigen lösungsmitteln | |
EP1125497A3 (de) | Mittel zur viruziden Händedesinfektion | |
MXPA04000028A (es) | Formulacion farmaceutica para la administracion intramuscular de fulvestrant. | |
KR880002524A (ko) | 니코란딜 외용제 | |
BR112021023276A2 (pt) | Cartucho compreendendo nicotina e um solvente imiscível em água | |
EP1245655A3 (en) | Thermosetting coating composition and coating film forming method using the same | |
WO2001049273A3 (de) | Pharmazeutische zusammensetzung zur transdermalen verabreichung von hormonen mit einem permeationsverbessernden zusatzstoff | |
AR002981A1 (es) | Un envase que aloja una composicion farmaceutica que comprende una solucion acuosa de clorhidrato de procaterol, y una composicion farmaceutica quecomprende una solucion acuosa de clorhidrato de procaterol | |
ATE14437T1 (de) | Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel. | |
DK0773884T3 (da) | Opløsningssystem til en flydende opløsning, der indeholder en aktiv ingrediens | |
CA2548739A1 (en) | Uv-stable, liquid or semisolid transdermal administration form comprising a photosensitive active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |